The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
choline which has recently been shown in studies like this one to improve the outcomes in people with apoe4 genotype in terms of Alzheimer's disease risk this is a study from MIT news it says the gene variant disrupts lipid metabolism but in cell experiments the effects were reversed by choline supplements
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.